Your browser doesn't support javascript.
loading
Impact of Albumin Assays in the Diagnosis of Malnutrition in Hemodialysis Patients: A Cohort Study.
Rami Arab, Lila; Dabernat, Sandrine; Boutin, Julian; Bordenave, Chloé; Karmani, Malek; Colombiès, Brigitte; Delmas, Yahsou; De-La-Faille, Renaud; De Précigout, Valérie; Rubin, Sébastien; Moreau, Karine; Bats, Marie-Lise.
Affiliation
  • Rami Arab L; CHU Bordeaux, Department of Biochemistry, Pellegrin Hospital, Bordeaux, France.
  • Dabernat S; CHU Bordeaux, Department of Biochemistry, Pellegrin Hospital, Bordeaux, France; University of Bordeaux, INSERM, Bordeaux Institute of Oncology BRIC U1312, Bordeaux, France.
  • Boutin J; CHU Bordeaux, Department of Biochemistry, Pellegrin Hospital, Bordeaux, France; University of Bordeaux, INSERM, Bordeaux Institute of Oncology BRIC U1312, Bordeaux, France.
  • Bordenave C; CHU Bordeaux, Department of Biochemistry, Pellegrin Hospital, Bordeaux, France.
  • Karmani M; CHU Bordeaux, Department of Biochemistry, Pellegrin Hospital, Bordeaux, France.
  • Colombiès B; CHU Bordeaux, Department of Biochemistry, Pellegrin Hospital, Bordeaux, France.
  • Delmas Y; CHU Bordeaux, Department of Nephrology, Transplantation, Dialysis, and Apheresis, Pellegrin Hospital, Bordeaux, France.
  • De-La-Faille R; CHU Bordeaux, Department of Nephrology, Transplantation, Dialysis, and Apheresis, Pellegrin Hospital, Bordeaux, France.
  • De Précigout V; CHU Bordeaux, Department of Nephrology, Transplantation, Dialysis, and Apheresis, Pellegrin Hospital, Bordeaux, France.
  • Rubin S; CHU Bordeaux, Department of Nephrology, Transplantation, Dialysis, and Apheresis, Pellegrin Hospital, Bordeaux, France; University of Bordeaux, INSERM, Biology of Cardiovascular Diseases U1034, Pessac, France.
  • Moreau K; CHU Bordeaux, Department of Nephrology, Transplantation, Dialysis, and Apheresis, Pellegrin Hospital, Bordeaux, France.
  • Bats ML; CHU Bordeaux, Department of Biochemistry, Pellegrin Hospital, Bordeaux, France; University of Bordeaux, INSERM, Biology of Cardiovascular Diseases U1034, Pessac, France. Electronic address: marie-lise.bats@chu-bordeaux.fr.
J Ren Nutr ; 33(2): 332-336, 2023 03.
Article in En | MEDLINE | ID: mdl-36270483
OBJECTIVE: In hemodialysis (HD) patients, malnutrition should be diagnosed by several assessment tools including a plasma albumin concentration of less than 3.8 g/dL or 3.5 g/dL using bromocresol green or immunonephelometry (IN), respectively. However, albumin measurement is not yet standardized and two alternative methods are also commonly used in laboratories: bromocresol purple (BCP) and immunoturbidimetry (IT). This study aimed to revisit the hypoalbuminemia thresholds for BCP and IT, in HD patients. METHODS: Plasma albumin was measured by the four analytical methods during the monthly HD nutritional assessment of 103 prospectively included patients. RESULTS: Significant differences in albumin levels were observed in HD patients depending on the method used. Using BCP or IT with the cut-off at 3.5 g/dL (determined for the general population) we obtained 33% and 9.7% of false hypoalbuminemia in comparison to IN (mean bias of -0.4 g/dL and -0.065 g/dL, respectively). The best hypoalbuminemia threshold for BCP was 3.05 g/dL and 3.4 g/dL for IT. Twenty percent of HD patients were classified as malnourished when albumin was determined by IN. Similar rates were obtained using the new hypoalbuminemia cut-offs for BCP (18.5%) and IT (19.5%). CONCLUSION: To avoid nutritional misclassification of HD patients, we should adjust hypoalbuminemia thresholds when BCP or IT methods are used in laboratories.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Renal Dialysis / Malnutrition Type of study: Diagnostic_studies / Etiology_studies / Observational_studies Limits: Humans Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Renal Dialysis / Malnutrition Type of study: Diagnostic_studies / Etiology_studies / Observational_studies Limits: Humans Language: En Year: 2023 Type: Article